Follow-The-Filings

ABUS · Arbutus Biopharma Corp.

Q4 2019 13F holders

← latest ownership dossier

Ticker
ABUS
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares